全文获取类型
收费全文 | 2442篇 |
免费 | 153篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 60篇 |
儿科学 | 145篇 |
妇产科学 | 24篇 |
基础医学 | 267篇 |
口腔科学 | 50篇 |
临床医学 | 356篇 |
内科学 | 481篇 |
皮肤病学 | 39篇 |
神经病学 | 276篇 |
特种医学 | 280篇 |
外国民族医学 | 5篇 |
外科学 | 179篇 |
综合类 | 24篇 |
预防医学 | 146篇 |
眼科学 | 28篇 |
药学 | 126篇 |
中国医学 | 5篇 |
肿瘤学 | 112篇 |
出版年
2021年 | 35篇 |
2020年 | 26篇 |
2019年 | 31篇 |
2018年 | 51篇 |
2017年 | 34篇 |
2016年 | 32篇 |
2015年 | 40篇 |
2014年 | 62篇 |
2013年 | 75篇 |
2012年 | 86篇 |
2011年 | 70篇 |
2010年 | 65篇 |
2009年 | 92篇 |
2008年 | 77篇 |
2007年 | 80篇 |
2006年 | 48篇 |
2005年 | 61篇 |
2004年 | 60篇 |
2003年 | 63篇 |
2002年 | 52篇 |
2001年 | 64篇 |
2000年 | 80篇 |
1999年 | 82篇 |
1998年 | 69篇 |
1997年 | 68篇 |
1996年 | 83篇 |
1995年 | 65篇 |
1994年 | 54篇 |
1993年 | 60篇 |
1992年 | 52篇 |
1991年 | 49篇 |
1990年 | 56篇 |
1989年 | 72篇 |
1988年 | 60篇 |
1987年 | 65篇 |
1986年 | 67篇 |
1985年 | 52篇 |
1984年 | 48篇 |
1983年 | 28篇 |
1982年 | 28篇 |
1981年 | 25篇 |
1980年 | 14篇 |
1979年 | 23篇 |
1978年 | 11篇 |
1977年 | 23篇 |
1976年 | 19篇 |
1975年 | 19篇 |
1974年 | 13篇 |
1972年 | 19篇 |
1970年 | 15篇 |
排序方式: 共有2603条查询结果,搜索用时 375 毫秒
1.
Grulois Daphné Tiavouane Josina Dumas Pascal Paul Fauvelot Cécile 《Conservation Genetics Resources》2015,7(1):73-75
Conservation Genetics Resources - Fifteen polymorphic microsatellite markers were developed for Tridacna maxima in order to assess self-recruitment and larval dispersal within and among MPAs in New... 相似文献
2.
R Mandeville F Dumas A Amarouch S Sidrac-Ghali M C Walker M Zelechowska I Ajdukovic B Grouix 《Hybridoma》1987,6(5):441-451
This study reports the purification and characterization of a high molecular weight human breast cancer-associated antigen identified by a previously described (1,2) murine monoclonal antibody, BCD-B4. Immunohistochemical analysis indicated that BCD-B4 recognizes an antigen expressed in an altered form on the human breast carcinoma cell line, BT-20, compared to the non-malignant human mammary epithelial cell line, HBL-100. Chemical treatments and enzymatic digestions suggested that the recognized moiety was a protein. The antigenic determinant was resistant to neuraminidase and periodate treatments but was sensitive to trypsin and proteinase K. The antigen was purified by affinity chromatography and its molecular weight, determined by SDS-PAGE analysis under non-reducing conditions, was proven to be 250 Kd. Under reducing conditions, the molecule dissociated into two polypeptides of 125 and 45 Kd, respectively. Both subunits could be isolated from normal HBL-100 and neoplastic BT-20 cellular protein extracts by affinity chromatography. The higher molecular weight subunit showed; however, qualitative and quantitative differences between the two cell lines: it was expressed in greater quantity on BT-20 cells and its molecular weight was 15 Kd higher. Both subunits could also be identified by immunoblots of BT-20 cells. 相似文献
3.
4.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
5.
Injections of the retrograde fluorescent tracer fast blue in the striatum (STR) and nuclear yellow in the internal segment of the globus pallidus (GPi) in the squirrel monkey (Saimiri sciureus) revealed a nigropallidal projection whose cellular origin was largely distinct from that of the nigrostriatal pathway. Neurons containing the tracer injected in GPi were scattered throughout the substantia nigra-ventral tegmental area complex where they formed approximately 20-25% of the total number of retrogradely labeled cells. Only about 5-10% of all positive neurons were double-labeled after STR-GPi injections. In experiments combining the use of the fluorescent tracer propidium iodide with immunofluorescence, the majority of neurons projecting to GPi displayed tyrosine hydroxylase immunoreactivity. Hence, in addition to their important role at striatal level, midbrain dopaminergic neurons may influence directly the output neurons of the basal ganglia at pallidal level in primates. 相似文献
6.
7.
J-P Lefaucheur J-J Labat G Amarenco A-G Herbaut D Prat-Pradal J Benaim B Aranda M-C Arne-Bes V Bonniaud P-M Boohs K Charvier F Daemgen P Dumas J-P Galaup S Sheikh Ismael J Kerdraon P Lacroix D Lagauche E Lapeyre M Lefort A-M Leroi R-J Opsomer B Parratte J-G Prévinaire P Raibaut J-Y Salle M-C Scheiber-Nogueira J-M Soler M-F Testut C Thomas 《Clinical neurophysiology》2007,37(4):223-228
Entrapment of the pudendal nerve may be at the origin of chronic perineal pain. This syndrome must be diagnosed because this can result in the indication of surgical decompression of the entrapped nerve for pain relief. Electroneuromyographic (ENMG) investigation is often performed in this context, based on needle electromyography and the study of sacral reflex and pudendal nerve motor latencies. The limits of ENMG investigation, owing to various pathophysiological and technical considerations, should be known. The employed techniques do not assess directly the pathophysiological mechanisms of pain but rather correlate to structural alterations of the pudendal nerve (demyelination or axonal loss). In addition, only direct or reflex motor innervation is investigated, whereas sensory nerve conduction studies should be more sensitive to detect nerve compression. Finally, ENMG cannot differentiate entrapment from other causes of pudendal nerve lesion (stretch induced by surgical procedures, obstetrical damage, chronic constipation...). Thus, perineal ENMG has a limited sensitivity and specificity in the diagnosis of pudendal nerve entrapment syndrome and does not give direct information about pain mechanisms. Pudendal neuralgia related to nerve entrapment is mainly suspected on specific clinical features and perineal ENMG examination provides additional, but no definitive clues, for the diagnosis or the localization of the site of compression. In fact, the main value of ENMG is to assess objectively pudendal motor innervation when a surgical decompression is considered. Perineal ENMG might predict the outcome of surgery but is of no value for intraoperative monitoring. 相似文献
8.
9.